Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124592733 | 12459273 | 3 | F | 2012 | 20160809 | 20160613 | 20160822 | EXP | PHEH2016US013560 | NOVARTIS | 82.00 | YR | F | Y | 0.00000 | 20160822 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124592733 | 12459273 | 1 | PS | LETROZOLE. | LETROZOLE | 1 | Unknown | 1 DF (1 DAILY) | U | 20726 | 1 | DF | |||||||
124592733 | 12459273 | 2 | SS | CALCIUM CITRATE | CALCIUM CITRATE | 1 | Unknown | 250 MG, UNK | U | 0 | 250 | MG | TABLET | ||||||
124592733 | 12459273 | 3 | SS | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
124592733 | 12459273 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 15 MG (15 MG OR 10 MG) | U | 0 | 15 | MG | TABLET | ||||||
124592733 | 12459273 | 5 | C | POTASSIUM | POTASSIUM | 1 | Unknown | 1 DF, (1 TABLET) | U | 0 | 1 | DF | TABLET | ||||||
124592733 | 12459273 | 6 | C | PREVALITE | CHOLESTYRAMINE | 1 | Unknown | U | 0 | POWDER | |||||||||
124592733 | 12459273 | 7 | C | DRAMAMINE | DIMENHYDRINATE | 1 | Unknown | AS NEEDED | U | 0 | |||||||||
124592733 | 12459273 | 8 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | AS NEEDED | U | 0 | |||||||||
124592733 | 12459273 | 9 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | Unknown | 1 DF, QD (1 TABLET DAILY) | U | 0 | 1 | DF | TABLET | QD | |||||
124592733 | 12459273 | 10 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124592733 | 12459273 | 1 | Breast cancer |
124592733 | 12459273 | 2 | Product used for unknown indication |
124592733 | 12459273 | 3 | Product used for unknown indication |
124592733 | 12459273 | 4 | Product used for unknown indication |
124592733 | 12459273 | 5 | Product used for unknown indication |
124592733 | 12459273 | 6 | Product used for unknown indication |
124592733 | 12459273 | 7 | Product used for unknown indication |
124592733 | 12459273 | 8 | Product used for unknown indication |
124592733 | 12459273 | 9 | Product used for unknown indication |
124592733 | 12459273 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124592733 | 12459273 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124592733 | 12459273 | Aortic valve incompetence | |
124592733 | 12459273 | Arthralgia | |
124592733 | 12459273 | Balance disorder | |
124592733 | 12459273 | Blood cholesterol increased | |
124592733 | 12459273 | Calcium metabolism disorder | |
124592733 | 12459273 | Dizziness | |
124592733 | 12459273 | Dysphonia | |
124592733 | 12459273 | Eye swelling | |
124592733 | 12459273 | Eyelid oedema | |
124592733 | 12459273 | Fall | |
124592733 | 12459273 | Foot fracture | |
124592733 | 12459273 | Gait disturbance | |
124592733 | 12459273 | Hearing disability | |
124592733 | 12459273 | Initial insomnia | |
124592733 | 12459273 | Oedema peripheral | |
124592733 | 12459273 | Osteoporosis | |
124592733 | 12459273 | Paraesthesia | |
124592733 | 12459273 | Rash | |
124592733 | 12459273 | Sciatica | |
124592733 | 12459273 | Spinal fracture | |
124592733 | 12459273 | Swelling face | |
124592733 | 12459273 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |